The loss of E-cadherin through genetic or epigenetic alterations is correlated with the aggressive behavior of lung cancer.4, 15, 16 Moreover, transcriptional repressors of E-cadherin are upregulated in lung cancer, associated with tumor progression and poor prognosis of patients.17, 18, 19, 20. This evidence concerns the gene CDH1 and lung carcinoma.